Back to Agendas
Session 0302 The Feasibility of Initiating Clinical Trials by Single IRB Approving in China
Speaker(s)
George Guo
Novartis Pharmaceuticals, China
Global Monitoring Operation Country Head
Winnie Xu
Quintiles Medical Development (Shanghai) Co. Ltd, China
AD
Huanling Wang
Peking Union Medical College Hospital, China
Vice Director, Clinical Pharmacology Research Center
What will be reviewed in multicenter ethical review units should review what?
YongChuan Chen
Xinan Hospital of Army Medical University, China
Director,Drug Clinical Trial Institute Office
Zhiqiang Ning
Shenzhen Chipscreen Biosciences, Ltd., China
Vice President, Research & Clinical Development
The feasibility of center ethical review implementation in China
Tim Shi
GlobalMD, United States
Executive Director
Have an account?